# OnCo record interstitial-lung-disease-on-antibody-drug-conjugates-and-targeted-drugs (protocol). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/protocols/interstitial-lung-disease-on-antibody-drug-conjugates-and-targeted-drugs/>
  a schema:MedicalGuideline ;
  onco:kind "protocol" ;
  schema:identifier "interstitial-lung-disease-on-antibody-drug-conjugates-and-targeted-drugs" ;
  schema:name "Interstitial lung disease on antibody-drug conjugates and targeted drugs: monitoring and management by grade"@en ;
  schema:alternateName "drug-induced ILD"@en, "drug-induced pneumonitis"@en, "trastuzumab deruxtecan ILD"@en, "T-DXd pneumonitis"@en, "Enhertu lung inflammation"@en, "osimertinib pneumonitis"@en, "everolimus non-infectious pneumonitis"@en, "CDK4/6 inhibitor pneumonitis"@en, "DIILD"@en ;
  schema:description "Some cancer drugs, above all trastuzumab deruxtecan, can inflame the lungs. It can show on a scan before there are any symptoms, and it is treated by pausing or stopping the drug and, often, steroids. The rules differ from drug to drug. A new or worsening cough, breathlessness or fever needs a call to your cancer team straight away, not at the next appointment."@en ;
  schema:url <https://onco.cc/protocols/interstitial-lung-disease-on-antibody-drug-conjugates-and-targeted-drugs/> ;
  schema:dateModified "2026-11-17"^^xsd:date ;
  onco:related <https://onco.cc/protocols/irae-pneumonitis/>, <https://onco.cc/protocols/pneumocystis-pneumonia-prophylaxis/>, <https://onco.cc/pairings/ild-overlap-caution/>, <https://onco.cc/drugs/methylprednisolone/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab-deruxtecan/>, <https://onco.cc/drugs/datopotamab-deruxtecan/>, <https://onco.cc/drugs/osimertinib/>, <https://onco.cc/drugs/abemaciclib/>, <https://onco.cc/drugs/ribociclib/>, <https://onco.cc/drugs/everolimus/>, <https://onco.cc/drugs/sotorasib/>, <https://onco.cc/drugs/olaparib/> ;
  onco:terms <https://onco.cc/terms/ild/>, <https://onco.cc/terms/pneumonitis/>, <https://onco.cc/terms/radiation-pneumonitis/>, <https://onco.cc/terms/ctcae-grading/> .
